反応式
[Cl:1][C:2]1[CH:9]=[CH:8][CH:7]=[CH:6][C:3]=1[CH:4]=O.[NH2:10][C:11]1[N:16]=[C:15]([NH2:17])[CH:14]=[C:13]([OH:18])[N:12]=1.[CH3:19][C:20]1[N:21]([CH2:27][CH2:28][O:29][CH2:30][C:31](=O)[CH2:32][C:33]([O:35][CH3:36])=[O:34])[C:22]([CH3:26])=[C:23]([CH3:25])[N:24]=1>>[NH2:10][C:11]1[NH:16][C:15]2[NH:17][C:31]([CH2:30][O:29][CH2:28][CH2:27][N:21]3[C:22]([CH3:26])=[C:23]([CH3:25])[N:24]=[C:20]3[CH3:19])=[C:32]([C:33]([O:35][CH3:36])=[O:34])[CH:4]([C:3]3[CH:6]=[CH:7][CH:8]=[CH:9][C:2]=3[Cl:1])[C:14]=2[C:13](=[O:18])[N:12]=1参加物
4
実験手順
The title compound (110 mg) was prepared from 2-chlorobenzaldehyde (1.05 g), 2,4-diamino-6-hydroxypyrimidine (1.07 g) and methyl 4-[2-(2,4,5-trimethylimidazol-1-yl)ethoxy]-3-oxobutanoate (2.0 g) by the method of Example 1. M.p. 225°-227° C.
出典と根拠
- ORDレコード
- ord-91bd0bf900344450b49d63a040290a98
- 出典データセット
- uspto-grants-1991_02
- 特許番号
- US04992447
関連ノート
読み込み中…